Heart Failure: all 5,803 studies

Page 14 of 59. Open to participants first (1,222), then studies with results posted, then the rest; newest registration first within each.

• The Re-Prosper HF StudyCompletedNCT04551222Phase 2/3Results posted
• Feasibility Study of the µCor Heart Failure and Arrhythmia Management System (PATCH)CompletedNCT04512703Results posted
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)CompletedNCT04509674Phase 3Results posted
• LINK-HF2 - Remote Monitoring Analytics in Heart FailureCompletedNCT04502563Not applicableResults posted
• Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)TerminatedNCT04491136Phase 4Results posted
• Percutaneous RVAD to Preemptively Treat Right Heart Failure Post-LVADTerminatedNCT04458103Not applicableResults posted
• Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart FailureCompletedNCT04452149Not applicableResults posted
• Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%CompletedNCT04435626Phase 3Results posted
• mHealth for Self-care of Heart Failure in UgandaCompletedNCT04426630Not applicableResults posted
• Global Prevalence of ATTR-CM in Participants With HFpEFTerminatedNCT04424914Not applicableResults posted
• Evaluating Efficacy of Digital Health Technology in the Treatment of Congestive Heart FailureCompletedNCT04394754Not applicableResults posted
• Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart FailureCompletedNCT04384653Phase 1/2Results posted
• Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)CompletedNCT04363697Phase 4Results posted
• Study of Verinurad in Heart Failure With Preserved Ejection FractionCompletedNCT04327024Phase 2Results posted
• Study of the Safety of BMS-986259 in Participants With Post-Acute Decompensated Heart FailureCompletedNCT04318093Phase 2Results posted
• Innovative Care of Older Adults With Chronic Heart Failure: A Comparative Effectiveness Clinical Trial (I-COACH)TerminatedNCT04304833Not applicableResults posted
• Efficacy and Safety of Dapagliflozin in Acute Heart FailureCompletedNCT04298229Phase 3Results posted
• Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)CompletedNCT04283994Not applicableResults posted
• Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)CompletedNCT04281784Not applicableResults posted
• A Study on Impact of Canagliflozin on Health Status, Quality of Life, and Functional Status in Heart FailureCompletedNCT04252287Phase 3Results posted
• Dapagliflozin at Discharge on Hospital Heart Failure ReadmissionCompletedNCT04249778Phase 4Results posted
• Leveraging Home Health Aides to Improve Outcomes in Heart FailureCompletedNCT04239911Not applicableResults posted
• The Left Ventricular Assist Device (LVAD) Off or On Pump Implantation StudyTerminatedNCT04219618Not applicableResults posted
• Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)CompletedNCT04210375Phase 1Results posted
• OptiVol for Precision Medical Management of Heart FailureTerminatedNCT04206501Not applicableResults posted
• Mid-Q Response StudyCompletedNCT04180696Not applicableResults posted
• Patient-Reported Outcome Measurement in Heart Failure ClinicCompletedNCT04164004Not applicableResults posted
• A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart FailureCompletedNCT04157751Phase 3Results posted
• Family Palliative and End-of-Life Care for Advanced Heart FailureCompletedNCT04153890Not applicableResults posted
• The Aortix CRS Pilot StudyCompletedNCT04145635Not applicableResults posted
• RELieving Increasing oEdema Due to Heart FailureTerminatedNCT04142788Phase 4Results posted
• Advancing Understanding of Transportation OptionsCompletedNCT04141891Not applicableResults posted
• Improving Patient Prioritization During Hospital-homecare TransitionCompletedNCT04136951Not applicableResults posted
• Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2CompletedNCT04113109Phase 4Results posted
• Developing Oral LT3 Therapy for Heart Failure - HFrEFCompletedNCT04112316Phase 1/2Results posted
• Developing Oral LT3 Therapy for Heart Failure - HFpEFCompletedNCT04111536Phase 1/2Results posted
• Daxor - Blood Volume AnalysisCompletedNCT04111185Not applicableResults posted
• Benefits of Microcor in Ambulatory Decompensated Heart FailureCompletedNCT04096040Not applicableResults posted
• Compression Wraps as Adjuvant Therapy in Management of Acute Systolic Heart FailureTerminatedNCT04095416Not applicableResults posted
• PROACTIVE-HF IDE Trial Heart Failure NYHA Class IIIActive, not recruitingNCT04089059Not applicableResults posted
• Evaluating Metabolic Mechanisms of Ertugliflozin in Diabetes & Heart FailureTerminatedNCT04071626Phase 4Results posted
• The ARIES HeartMate 3 Pump IDE StudyCompletedNCT04069156Not applicableResults posted
• Functional Exercise and Nutrition Education Program for Older AdultsCompletedNCT04037436Not applicableResults posted
• Vitamin C Supplementation InterventionCompletedNCT04036110Not applicableResults posted
• Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCCCompletedNCT04023227Phase 4Results posted
• Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or TrastuzumabCompletedNCT04023110Phase 1Results posted
• Assessment of Pulmonary Congestion During Cardiac Hemodynamic Stress TestingTerminatedNCT04019613Not applicableResults posted
• Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)CompletedNCT03988634Phase 3Results posted
• Improving Self-care of Heart Failure CaregiversCompletedNCT03988621Phase 2Results posted
• Heart Failure Resilience Intervention for CaregiversCompletedNCT03963583Not applicableResults posted
• Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral IntakeCompletedNCT03962101Phase 3Results posted
• Sensor-controlled Digital Game for Heart Failure Self-managementCompletedNCT03947983Not applicableResults posted
• Effects of Echo-optimization of Left Ventricular Assist Devices on Functional Capacity (VAFRACT)CompletedNCT03937570Not applicableResults posted
• NHLBI DIR Transcatheter Mitral Cerclage Annuloplasty Early Feasibility StudyCompletedNCT03929913Not applicableResults posted
• COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart FailureCompletedNCT03917459Phase 3Results posted
• An Open-label Extension Study Evaluating Safety and Tolerability of LCZ696 in Subjects Who Completed PARAGON-HF in Japan.TerminatedNCT03909295Phase 3Results posted
• Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)CompletedNCT03888066Phase 3Results posted
• DETERMINE-reduced - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Reduced Ejection FractionCompletedNCT03877237Phase 3Results posted
• DETERMINE-preserved - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Preserved Ejection FractionCompletedNCT03877224Phase 3Results posted
• Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority PopulationsCompletedNCT03812172Results posted
• FAST PV and mGFR™ Technology in Congestive Heart FailureCompletedNCT03808948Not applicableResults posted
• Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2CompletedNCT03797001Phase 2Results posted
• Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HFCompletedNCT03785405Phase 3Results posted
• Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart FailureCompletedNCT03772041Phase 3Results posted
• Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart FailureCompletedNCT03759392Phase 3Results posted
• Safety and Tolerability Study of AZD4831 in Patients With Heart Failure.TerminatedNCT03756285Phase 2Results posted
• Project to Improve Communication About Serious Illness - Pilot StudyCompletedNCT03746392Not applicableResults posted
• Diuretic Effect of Metolazone Pre-dosing Versus Concurrent DosingTerminatedNCT03746002Phase 4Results posted
• The Impact of Low Flow Nocturnal Oxygen Therapy on Hospital Admissions and Mortality in Patients With Heart Failure and Central Sleep ApneaTerminatedNCT03745898Phase 3Results posted
• An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop DiureticCompletedNCT03730961Phase 2Results posted
• Nicotinamide Riboside in LVAD RecipientsCompletedNCT03727646Early Phase 1Results posted
• Facilitating Communication StudyCompletedNCT03721952Not applicableResults posted
• Effect of Ertugliflozin on Cardiac Function in DiabetesCompletedNCT03717194Phase 3Results posted
• Apogee, A HeartWare HVAD Destination Product Surveillance Registry (PSR) PlatformCompletedNCT03697980Results posted
• Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 YearsCompletedNCT03694392Results posted
• Personalized Treatments for Depressive Symptoms in Patients With Advanced Heart FailureCompletedNCT03688100Phase 4Results posted
• Danger Signs in Heart Failure- Effects of Video EducationCompletedNCT03657459Not applicableResults posted
• Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of BenefitCompletedNCT03648762Not applicableResults posted
• The Improving ATTENDance to Cardiac Rehabilitation TrialCompletedNCT03646760Not applicableResults posted
• Patient-centered Mobile Health Intervention to Improve Self-care in Patients With Chronic Heart FailureCompletedNCT03642275Not applicableResults posted
• Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.CompletedNCT03619213Phase 3Results posted
• Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)TerminatedNCT03615469Not applicableResults posted
• Myeloperoxidase (MPO) Inhibitor A_Zeneca for Heart Failure With Preserved Ejection Fraction (HFpEF)CompletedNCT03611153Phase 1/2Results posted
• Relationship Between LINQ™ Subcutaneous Impedance and Right-sided Hemodynamic MeasurementsCompletedNCT03608826Not applicableResults posted
• Mind Your Heart StudyCompletedNCT03571581Not applicableResults posted
• The Effect of Nicotinamide Riboside on Skeletal Muscle Function in Heart Failure SubjectsTerminatedNCT03565328Phase 2Results posted
• Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1CompletedNCT03560323Phase 1Results posted
• Effects of Family Sodium Watcher Program on Outcomes in Heart Failure Patient-Family Caregiver DyadsCompletedNCT03560206Not applicableResults posted
• Patient-reported Outcomes in Vericiguat-treated Patients With HFpEFCompletedNCT03547583Phase 2Results posted
• Diabetes and Lipid Accumulationand Heart TransplantCompletedNCT03546062Results posted
• Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEFCompletedNCT03541603Phase 2Results posted
• Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart FailureTerminatedNCT03532009Phase 2Results posted
• Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)TerminatedNCT03521934Phase 3Results posted
• Phase I Study of OPC-61815CompletedNCT03510663Phase 1Results posted
• REALIsM-HF Pilot StudyCompletedNCT03507439Not applicableResults posted
• Circulating NEP and NEP Inhibition Study in Heart Failure With Preserved Ejection FractionCompletedNCT03506412Phase 4Results posted
• Acetazolamide in Decompensated Heart Failure With Volume OveRload (ADVOR)CompletedNCT03505788Phase 4Results posted
• ECG Belt for CRT ResponseCompletedNCT03504020Not applicableResults posted
• Patient and Family Partners in Heart Failure Care: Pilot Test of a Pre-visit Question Prompt List to Enhance Engagement During Medical VisitsCompletedNCT03491800Not applicableResults posted
• Benefits of µCor in Ambulatory Decompensated Heart FailureCompletedNCT03476187Not applicableResults posted

← Heart Failure overview